These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The natural history of the subacute sclerosing encephalitis. Lesny I; Dittrich J; Vymazal J Neurol India; 1969; 17(2):51-8. PubMed ID: 5823283 [No Abstract] [Full Text] [Related]
46. [SOME PROBLEMS IN THE DIAGNOSIS OF SUBACUTE SCLEROSING LEUKOENCEPHALITIS OR SUBACUTE PANENCEPHALITIS FROM THE VIEWPOINT OF THE PSYCHIATRIST]. KOLAR O; KLAPETEK J Cesk Psychiatr; 1964 Apr; 60():107-13. PubMed ID: 14152317 [No Abstract] [Full Text] [Related]
47. The clinical spectrum and early diagnosis of Dawson's encephalitis, with preliminary notes on treatment. Freeman JM J Pediatr; 1969 Oct; 75(4):590-603. PubMed ID: 4185707 [No Abstract] [Full Text] [Related]
48. Acute focal inclusion encephalitis a clinical pathological entity heretofore unrecognized in Israel (a study of 10 cases). Behar A Neuropatol Pol; 1966; 4():Suppl:503-15. PubMed ID: 4307253 [No Abstract] [Full Text] [Related]
49. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-1974. N Engl J Med; 1974 Jan; 290(5):273-9. PubMed ID: 4358056 [No Abstract] [Full Text] [Related]
50. Light and electron microscopy observations on the development of viral particles in the inclusions of Dawson's encephalitis (subacute sclerosing panencephalitis). Herndon RM; Rubinstein LJ Neurology; 1968 Jan; 18(1 Pt 2):8-20. PubMed ID: 4170005 [No Abstract] [Full Text] [Related]
51. [Case of subacute inclusion encephalitis]. Shinohara T; Kuramae T; Takahata N No To Shinkei; 1969 Apr; 21(4):375-80. PubMed ID: 4184460 [No Abstract] [Full Text] [Related]
52. Remarks on the EEG and movement disorder in SSPE. Lombroso CT Neurology; 1968 Jan; 18(1 Pt 2):69-75. PubMed ID: 5688847 [No Abstract] [Full Text] [Related]
53. Immunopathologic processes in the pathogenesis and manifestation of viral encephalitides. Seitelberger F Int Arch Allergy Appl Immunol; 1969; 36():Suppl:408-19. PubMed ID: 5373039 [No Abstract] [Full Text] [Related]
54. [Clinico-morphologic correlations and the etiology of progressive leukoencephalitis]. Leonovich AL; Pashkovakaia MI; Krasil'nikova NIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(12):1798-1803. PubMed ID: 4375374 [No Abstract] [Full Text] [Related]
55. Subacute sclerosing panencephalitis in children: prevalence in South China. Ip P; Chung BH; Wong VC; Chan KY Pediatr Neurol; 2004 Jul; 31(1):46-51. PubMed ID: 15246492 [TBL] [Abstract][Full Text] [Related]
56. Chronic sclerosing panencephalitis. I. A histological and lipid-histochemical study. Haltia M; Sourander P; Svennerholm L Acta Neuropathol; 1970; 14(4):284-92. PubMed ID: 5412438 [No Abstract] [Full Text] [Related]
57. Measles, mumps, rubella vaccine induced subacute sclerosing panencephalitis. Belgamwar RB; Prasad S; Appaya P J Indian Med Assoc; 1997 Nov; 95(11):594. PubMed ID: 9567594 [TBL] [Abstract][Full Text] [Related]
58. [Subacute sclerosing leukoencephalitis. Clinical and electroencephalographic study during the evolutive course of 14 cases]. Albert Lasierra P; Mármol Plaza D Rev Clin Esp; 1965 Oct; 99(2):115-21. PubMed ID: 5865075 [No Abstract] [Full Text] [Related]
59. Chronic necrotizing encephalitis involving mainly the grey matter of the temporo-rhinencephalic and insular regions. Ishino H; Nomura S; Sarai K Folia Psychiatr Neurol Jpn; 1973; 27(1):29-41. PubMed ID: 4740427 [No Abstract] [Full Text] [Related]
60. Subacute sclerosing panencephalitis should be eliminated by measles vaccination. Liu WL; He ZX; Li F; He D; Ai R Hum Vaccin Immunother; 2017 Sep; 13(9):2038-2040. PubMed ID: 28750182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]